Name: UMIN ID:
Unique ID issued by UMIN | C000000057 |
---|---|
Receipt number | R000000053 |
Scientific Title | Phase III Randomized Adjuvant Study of Exemestane Versus Anastrozole Versus Tamoxifen in Hormone-Responsive Postmenopausal Breast Cancer Patients |
Date of disclosure of the study information | 2005/08/12 |
Last modified on | 2016/02/19 14:38:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/08/12 13:35:35 | ||
2 | Update | 2005/08/12 13:49:18 | Date of disclosure of the study information |
|
3 | Update | 2005/08/12 13:54:33 | Date of disclosure of the study information |
|
4 | Update | 2005/08/21 18:03:16 | Blocking |
|
5 | Update | 2005/09/06 18:05:06 | ||
6 | Update | 2005/09/06 18:05:28 | Classification by specialty |
|
7 | Update | 2005/12/05 15:32:14 | ||
8 | Update | 2006/04/21 20:51:12 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
9 | Update | 2006/04/21 21:19:27 | Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Interventions/Control_3 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
10 | Update | 2006/04/21 21:26:09 | Division name Division name Address Address Homepage URL Organization1 Address1 |
|
11 | Update | 2006/04/21 21:29:39 | Recruitment status Other related information |
|
12 | Update | 2007/08/27 18:59:21 | Interventions/Control_3 |
|
13 | Update | 2010/08/20 20:17:57 | Publication of results URL related to results and publications |
|
14 | Update | 2010/11/01 11:16:29 | UMIN ID1 |
|
15 | Update | 2010/11/01 11:24:19 | Email |
|
16 | Update | 2011/06/28 15:16:02 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Institute Institute Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
17 | Update | 2011/06/29 10:11:44 | Institute |
|
18 | Update | 2013/05/31 13:47:25 | Organization Organization Organization |
|
19 | Update | 2014/02/14 14:44:40 | Email Last name of contact person Last name of contact person |
|
20 | Update | 2014/03/03 16:50:26 | Name of person sending information Name of person sending information |
|
21 | Update | 2015/08/17 16:41:42 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
22 | Update | 2016/02/19 14:37:17 | Recruitment status |
|
23 | Update | 2016/02/19 14:38:11 | Division name Division name |